Loading...
Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy
Background and objective The rate of end-stage renal disease from lupus nephritis has not declined, in spite of recent advances in therapeutics, such as mycophenolate mofetil (MMF). To provide insight into rates of the clinical outcomes in current practice after biopsy-proven lupus nephritis, we use...
Saved in:
| Published in: | Cureus |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Cureus
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796813/ https://ncbi.nlm.nih.gov/pubmed/29410944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1907 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|